A detailed history of Wolverine Trading, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Wolverine Trading, LLC holds 29,800 shares of LQDA stock, worth $340,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,800
Previous 15,654 90.37%
Holding current value
$340,316
Previous $187,000 59.36%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$11.96 - $15.71 $138,365 - $181,748
-11,569 Reduced 42.5%
15,654 $187,000
Q1 2024

May 15, 2024

BUY
$11.35 - $16.73 $308,981 - $455,440
27,223 New
27,223 $401,000
Q3 2023

Nov 15, 2023

BUY
$6.27 - $8.15 $98,326 - $127,808
15,682 New
15,682 $99,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $735M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.